Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia. | Pan Afr Med J | 2021 | 34422195 | PubTator, text mining | PubMed |
| XPF -673C>T variation is associated with the susceptibility to breast cancer. | Cancer Epidemiol | 2021 | 34416547 | PubTator, text mining | PubMed |
| An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches (Review). | Biomed Rep | 2021 | 34405046 | PubTator, text mining | PubMed |
| Crystal structure of the INTS3/INTS6 complex reveals the functional importance of INTS3 dimerization in DSB repair. | Cell Discov | 2021 | 34400606 | PubTator, text mining | PubMed |
| Large chromosomal deletions and impaired homologous recombination repairing in HEK293T cells exposed to polychlorinated biphenyl 153. | PeerJ | 2021 | 34395077 | PubTator, text mining | PubMed |
| Type I Interferon Induction in Cutaneous DNA Damage Syndromes. | Front Immunol | 2021 | 34381458 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and DNA repair systems. | Turk J Biol | 2021 | 34377049 | PubTator, text mining | PubMed |
| Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. | Aging (Albany NY) | 2021 | 34370715 | PubTator, text mining | PubMed |
| CometChip enables parallel analysis of multiple DNA repair activities. | DNA Repair (Amst) | 2021 | 34365116 | PubTator, text mining | PubMed |
| Pharmacoinformatics and UPLC-QTOF/ESI-MS-Based Phytochemical Screening of Combretum indicum against Oxidative Stress and Alloxan-Induced Diabetes in Long-Evans Rats. | Molecules | 2021 | 34361788 | PubTator, text mining | PubMed |
| Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment. | Int J Mol Sci | 2021 | 34360968 | PubTator, text mining | PubMed |
| Isoconazole and Clemizole Hydrochloride Partially Reverse the Xeroderma Pigmentosum C Phenotype. | Int J Mol Sci | 2021 | 34360928 | PubTator, text mining | PubMed |
| Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies. | Cancers (Basel) | 2021 | 34359720 | PubTator, text mining | PubMed |
| Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma. | Cancers (Basel) | 2021 | 34359660 | PubTator, text mining | PubMed |
| Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34359655 | PubTator, text mining | PubMed |
| A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes. | Cancer Chemother Pharmacol | 2021 | 34347127 | PubTator, text mining | PubMed |
| R-loop modulated epigenetic regulation in T helper cells mechanistically associates coronary artery disease and non-small cell lung cancer. | Transl Oncol | 2021 | 34343853 | PubTator, text mining | PubMed |
| PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. | Nat Commun | 2021 | 34330913 | PubTator, text mining | PubMed |
| FANCD2 limits acetaldehyde-induced genomic instability during DNA replication in esophageal keratinocytes. | Mol Oncol | 2021 | 34328261 | PubTator, text mining | PubMed |
| Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. | BMC Pediatr | 2021 | 34325699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=42